Cognizant Techno (CTSH) Shareholder Swedbank Has Upped Its Position by $8.37 Million

Adjust Comment Print

Express Scripts Holding Company (ESRX) has a market cap of $42.58 billion and over the last 12 months, Express Scripts Holding Company (NASDAQ:ESRX) has gone stronger by 8.7%. The Company operates through four segments: Financial Services, Healthcare, Manufacturing/Retail/Logistics, and Other. It has a 22.33 P/E ratio. This activity has been headed largely by Dsouza, an officer of the company.

Gogo Inc. (GOGO) stock moved with shift of 4.68% in the past week. (NASDAQ:VSAR) is a huge mover today! Its mean Altman Z-Score: 10.23 during the last 7 years, while average Beneish M-Score: -2.38 during the last 7 years. Scotia Capital holds 0.03% or 29,615 shares. We have $2.02 PT which if reached, will make NASDAQ:VSAR worth $3.01M less. Lowes Companies now has $75.08B valuation. The firm is developing VRS-317, a long-acting recombinant human growth hormone, which is in Phase III clinical trials for the treatment of growth hormone deficiency.

Analysts await Recro Pharma, Inc. (NASDAQ:BIDU) to report earnings on February, 22. They expect $-0.78 earnings per share, up 3.70% or $0.03 from last year's $-0.81 per share.

The company's Average Earnings Estimate for the Current Fiscal quarter is $0.97, according to consensus of 27 analysts.

Investors sentiment increased to 1.03 in 2017 Q3. Its up 0.01, from 1.03 in 2017Q2. New Mexico Educational Retirement Board reported 54,778 shares or 0.19% of all its holdings. Finally, Oak Ridge Investments LLC raised its stake in shares of Cognizant Technology Solutions by 7.1% in the second quarter.

Shares of Cognizant Technology Solutions Corp (CTSH) traded down $0.31 on Friday, reaching $72.40. Bridges Invest Management accumulated 0.3% or 31,804 shares. Argent Trust reported 3,530 shares. (NASDAQ:VSAR). Tiaa Cref Inv Mngmt Ltd Liability Corp invested 0% of its portfolio in Versartis, Inc. Moreover, Chem State Bank has 0.12% invested in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). (NASDAQ:VSAR) for 21,860 shares. Amica Retiree Tru holds 10,475 shares or 0.6% of its portfolio. The stock's Dividend Yield stands at 0.83%. Parametric Llc has 0% invested in MaxLinear, Inc. (NASDAQ:VSAR) for 32,550 shares. Following the completion of the transaction, the insider now directly owns 5,888 shares in the company, valued at $353,280. Td Asset Mgmt invested in 5.27M shares or 0.38% of the stock. (NASDAQ:VSAR). 4,500 are held by Great West Life Assurance Company Can. De Burlo has 116,700 shares. Ubs Oconnor Ltd Liability Com reported 420,000 shares. FMR LLC lifted its position in shares of Cognizant Technology Solutions by 81.6% in the 2nd quarter. Therefore 77% are positive. The Higher end of the revenue forecast is $3.87 Billion, while the Lower end of the forecast is $3.76 Billion. The stock has a consensus rating of "Buy" and an average target price of $65.52.

Roche to Buy US Cancer-Drug Maker Ignyta for $1.7 Billion
The key solid tumors being explored in the trial are non-small cell lung cancer (NSCLC) and metastatic colorectal cancer (mCRC). Citi is acting as financial advisor to Roche and Sidley Austin LLP is acting as legal counsel to Roche .

Cognizant Technology Solutions Corporation (NASDAQ:CTSH) touched its 1-Year High price of $76.51 on 10/31/17 and its 1-Year Low price of $51.52 on 01/31/17. SunTrust initiated Versartis, Inc. The rating was downgraded by Bank of America to "Underperform" on Tuesday, November 22. The firm has "Hold" rating by Argus Research given on Friday, September 30. The firm has "Buy" rating given on Thursday, November 2 by Credit Suisse. The stock has "Buy" rating by Cowen & Co on Thursday, October 12. The firm earned "Neutral" rating on Friday, September 22 by PiperJaffray. The rating was maintained by Needham with "Buy" on Tuesday, February 9. Royal Bank of Canada reissued a "buy" rating and set a $77.00 price target on shares of Cognizant Technology Solutions in a research report on Wednesday, September 6th. Shaheen Allen also sold $31,196 worth of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) shares. (NASDAQ:VSAR) or 1,326 shares. $697,469 worth of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) was sold by GOMATAM SUMITHRA. The rating was upgraded by Zacks to "Sell" on Monday, August 17. Barclays upped their price objective on shares of Cognizant Technology Solutions from $80.00 to $90.00 and gave the company an "overweight" rating in a research note on Monday, October 30th.

Cognizant Technology Solutions Corporation (NASDAQ:CTSH) reported its EPS in the last quarter as $0.98/Share beating the analyst estimate of $0.96/Share by a difference of $0.02. CTSH's profit will be $518.88 million for 20.38 P/E if the $0.88 EPS becomes a reality. The institutional investor held 127,438 shares of the edp services company at the end of 2017Q3, valued at $9.24 million, up from 119,990 at the end of the previous reported quarter.

Cognizant Technology Solutions Corporation (CTSH) has declined -0.43% and closed its last trading session at $72.4. About 8.48M shares traded.

Keeping an eyeball on Gross profit Margin, Net profit Margin & Operating Margin, the Gross profit margin of 39.60%; the net profit margin of 13.40% while its Operating margin was 16.50% for Cognizant Technology Solutions Corporation (CTSH). It has underperformed by 11.20% the S&P500.

Since August 4, 2017, it had 0 insider purchases, and 32 sales for $25.05 million activity. Middleton Sean also sold $2,364 worth of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) shares. Harding Loevner Lp owns 3.54 million shares or 0.98% of their U.S. portfolio. Given that its average daily volume over the 30 days has been 3.32M shares a day, this signifies a pretty significant change over the norm. The New York-based Opus Point Partners Management Llc has invested 0.2% in the stock. Matthews International Capital Management Llc, a California-based fund reported 3.72 million shares.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.